Lee Dale Y, Wetzsteon Rachel J, Zemel Babette S, Shults Justine, Organ Jason M, Foster Bethany J, Herskovitz Rita M, Foerster Debbie L, Leonard Mary B
Department of Pediatrics, Children's Hospital of Philadelphia (CHOP), Philadelphia, PA, USA.
J Bone Miner Res. 2015 Mar;30(3):575-83. doi: 10.1002/jbmr.2375.
Measures of muscle mass or size are often used as surrogates of forces acting on bone. However, chronic diseases may be associated with abnormal muscle force relative to muscle size. The muscle-bone unit was examined in 64 children and adolescents with new-onset Crohn's disease (CD), 54 with chronic kidney disease (CKD), 51 treated with glucocorticoids for nephrotic syndrome (NS), and 264 healthy controls. Muscle torque was assessed by isometric ankle dynamometry. Calf muscle cross-sectional area (CSA) and tibia cortical section modulus (Zp) were assessed by quantitative CT. Log-linear regression was used to determine the relations among muscle CSA, muscle torque, and Zp, adjusted for tibia length, age, Tanner stage, sex, and race. Muscle CSA and muscle torque-relative-to-muscle CSA were significantly lower than controls in advanced CKD (CSA -8.7%, p = 0.01; torque -22.9%, p < 0.001) and moderate-to-severe CD (CSA -14.1%, p < 0.001; torque -7.6%, p = 0.05), but not in NS. Zp was 11.5% lower in advanced CKD (p = 0.005) compared to controls, and this deficit was attenuated to 6.7% (p = 0.05) with adjustment for muscle CSA. With additional adjustment for muscle torque and body weight, Zp was 5.9% lower and the difference with controls was no longer significant (p = 0.09). In participants with moderate-to-severe CD, Zp was 6.8% greater than predicted (p = 0.01) given muscle CSA and torque deficits (R(2) = 0.92), likely due to acute muscle loss in newly-diagnosed patients. Zp did not differ in NS, compared with controls. In conclusion, muscle torque relative to muscle CSA was significantly lower in CKD and CD, compared with controls, and was independently associated with Zp. Future studies are needed to determine if abnormal muscle strength contributes to progressive bone deficits in chronic disease, independent of muscle area. © 2014 American Society for Bone and Mineral Research.
肌肉质量或大小的测量常常被用作作用于骨骼的力量的替代指标。然而,慢性疾病可能与相对于肌肉大小的异常肌肉力量有关。对64名新诊断为克罗恩病(CD)的儿童和青少年、54名患有慢性肾病(CKD)的患者、51名因肾病综合征(NS)接受糖皮质激素治疗的患者以及264名健康对照者的肌肉-骨骼单元进行了检查。通过等长踝关节测力法评估肌肉扭矩。通过定量CT评估小腿肌肉横截面积(CSA)和胫骨皮质截面模量(Zp)。采用对数线性回归来确定在根据胫骨长度、年龄、坦纳分期、性别和种族进行调整后,肌肉CSA、肌肉扭矩和Zp之间的关系。在晚期CKD患者中,肌肉CSA以及相对于肌肉CSA的肌肉扭矩显著低于对照组(CSA降低8.7%,p = 0.01;扭矩降低22.9%,p < 0.001),在中度至重度CD患者中也是如此(CSA降低14.1%,p < 0.001;扭矩降低7.6% , p = 0.05),但在NS患者中并非如此。与对照组相比,晚期CKD患者的Zp降低了11.5%(p = 0.005),在对肌肉CSA进行调整后,这一缺陷减弱至6.7%(p = 0.05)。在对肌肉扭矩和体重进行额外调整后,Zp降低了5.9%,与对照组的差异不再显著(p = 0.09)。在中度至重度CD患者中,考虑到肌肉CSA和扭矩不足,Zp比预测值高6.8%(p = 0.01)(R² = 0.92),这可能是由于新诊断患者的急性肌肉流失所致。与对照组相比,NS患者中的Zp没有差异。总之,与对照组相比,CKD和CD患者中相对于肌肉CSA的肌肉扭矩显著降低,并且与Zp独立相关。未来需要开展研究以确定异常肌肉力量是否独立于肌肉面积而导致慢性疾病中骨骼的渐进性缺陷。© 2014美国骨与矿物质研究学会